CBAY

Cymabay Therapeutics Stock Price

6.20
0.47 (8.2%)
Upgrade to Real-Time
Afterhours (Closed)
6.20
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Cymabay Therapeutics Inc CBAY NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.47 8.2% 6.20 5.67 6.30 5.68 5.73 00:00:08
Bid Price Ask Price Spread Spread % News
6.15 6.20 0.05 0.81% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
26,463 5,422,641 $ 6.09 $ 33,049,682 5,322,232 1.01 - 6.56
Last Trade Time Type Quantity Stock Price Currency
19:59:21 formt 100 $ 6.20 USD

Cymabay Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 427.07M 68.88M 68.61M $ - $ - -1.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cymabay Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBAY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.856.303.474.9614,695,8622.3561.04%
1 Month3.316.303.164.606,839,7522.8987.31%
3 Months3.836.303.164.353,412,9002.3761.88%
6 Months1.576.301.13013.743,071,3364.63294.9%
1 Year5.516.561.013.392,238,9650.6912.52%
3 Years7.1515.591.016.371,308,754-0.95-13.29%
5 Years2.9115.590.82016.00922,9533.29113.06%

Cymabay Therapeutics Description

CymaBay Therapeutics Inc is a part of the healthcare sector based in the United States. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being evaluated as a therapeutic agent for patients with Type 2 diabetes and MBX-8025 is a selective agonist for the peroxisome proliferator-activated receptor delta.


Your Recent History
NASDAQ
CBAY
Cymabay Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.